Connecting you to content on EBSCOhost

Works by Llinares, Julia

Results: 5

1

Cost-Effectiveness of Elranatamab Versus Current Therapies for the Management of Patients with Triple-Class Exposed, Relapsed and Refractory Multiple Myeloma, Including Other Bispecific and Physician's Choice of Treatment in Spain.

Published in:

Oncology & Therapy, 2025, v. 13, n. 2, p. 381, doi. 10.1007/s40487-025-00333-7

By:

Encinas, Cristina;
Lozano, Virginia;
Hlavacek, Patrick;
Llinares, Julia;
Toribio-Castelló, Sofía;
Carcedo, David;
Asís-Montalt, Jordi;
Martínez-López, Joaquín

Publication type:

Article

2

Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain [Corrigendum].

Published in:

ClinicoEconomics & Outcomes Research, 2021, v. 13, p. 645, doi. 10.2147/CEOR.S328284

By:

Mareque, Maria;
Montesinos, Pau;
Font, Patricia;
Guinea, José María;
de la Fuente, Adolfo;
Soto, Javier;
Oyagüez, Itziar;
Brockbank, James;
Iglesias, Tamara;
Llinares, Julia;
Sierra, Jorge

Publication type:

Article

3

Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain.

Published in:

ClinicoEconomics & Outcomes Research, 2021, v. 13, p. 263, doi. 10.2147/CEOR.S302097

By:

Mareque, Maria;
Montesinos, Pau;
Font, Patricia;
Guinea, José María;
de la Fuente, Adolfo;
Soto, Javier;
Oyagüez, Itziar;
Brockbank, James;
Iglesias, Tamara;
Llinares, Julia;
Sierra, Jorge

Publication type:

Article

4

Development and validation of a sexual relations satisfaction scale in patients with breast cancer - "SEXSAT-Q".

Published in:

2019

By:

Mancha, Rosario González;
Muñoz, Montserrat;
de la Cruz-Merino, Luis;
Calvo, Lourdes;
Cruz, Josefina;
Baena-Cañada, Jose Manuel;
Fernandez, Yolanda;
Ramos, Manuel;
Rodriguez, Cesar Augusto;
Chacón, Jose Ignacio;
Palomero, Isabel;
Llinares, Julia;
Rivero, María;
Ruiz, Miguel Ángel

Publication type:

journal article

5

Experience with Sunitinib in metastatic renal cell carcinoma (mRCC) patients: pooled analysis from 3 Spanish observational prospective studies.

Published in:

Expert Opinion on Drug Safety, 2018, v. 17, n. 6, p. 573, doi. 10.1080/14740338.2017.1330410

By:

Castellano, Daniel;
Maroto, José Pablo;
Espinosa, Enrique;
Grande, Enrique;
Bolós, M Victoria;
Llinares, Julia;
Esteban, Emilio;
González del Alba, Aranzazu;
Climent, Miguel Angel;
Arranz, Jose Angel;
Méndez, Mª José;
Fernández Parra, Eva;
Antón-Aparicio, Luis;
Bayona, Cristina;
Gallegos, Isabel;
Gallardo, Enrique;
Samaniego, Luz;
García Donas, Jesús

Publication type:

Article